Artemis Therapeutics Inc. ATMS
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 55.79M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- —
- High
- —
- Earnings
- Nov 14, 2022
MAX chart
Chart tools
Chart is warming up
The all-time price history for ATMS has not been loaded yet. Try again in a moment.
Altman Z-Score
-81.90 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -116×
P/S 212822×
P/B -64510×
P/FCF -159105×
EV/EBITDA -49284×
EV/Sales 212823×
FCF Yield -0.0%
Gross Margin 82.6%
Operating Margin -437.0%
Net Margin -434.4%
ROE 131.7%
ROIC 213.7%
ROA -509.8%
Revenue 0.0%
Operating Income -782.5%
EPS (diluted) -44.9%
Free Cash Flow -469.9%
Current Ratio 0.1×
Quick Ratio 0.1×
Debt / Equity -0.3×
Net Debt / EBITDA -0.2×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31